Protein redesign

Current Opinion in Structural Biology

Volumn 9, Issue 4, 1999, Pages 494-499

  Regan, Lynne ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; RANDOMIZATION; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0033179051     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(99)80070-0     Document Type: Article

References (24)

1. Nagi AD, Regan L: An inverse correlation between loop length and protein stability in a four helix bundle protein. Fold Des 1997, 2:67-75.
2. Nagi AD, Anderson KS, Regan L: Using loop length variants to dissect the folding pathway of a four-helix-bundle protein. J Mol Biol 1999, 286:257-265. The study of the behavior of loop-length variants aids in the dissection of a folding pathway.
3. Ladurner AG, Fersht AR: Glutamine, alanine and glycine repeats inserted into the loop of a protein have minimal effects on stability and folding rates. J Mol Biol 1997, 273:330-337.
4. Robinson CR, Sauer RT: Equilibrium stability and sub-millisecond folding of a designed single chain Arc repressor. Biochemistry 1996, 35:13878-13884.
5. Robinson CR, Sauer RT: Optimizing the stability of single-chain proteins by linker length and composition mutagenesis. Proc Natl Acad Sci USA 1998, 95:5929-5934. Genetic selection reveals energetically optimal loop sequences and provides guidelines for future redesigns.
6. Goldenberg DP, Creighton TE: Folding pathway of a circular form of bovine pancreatic trypsin inhibitor. J Mol Biol 1984, 179:527-545
7. Luger K, Hommel U, Hofsteenge J, Kirschner K: Correct folding of circularly permuted variants of a beta alpha barrel enzyme in vivo. Science 1989, 243:206-210.
8. Buchwalder A, Szadkowski H, Kirschner K: A fully active variant of dihydrofolate reductase with a circularly permuted sequence. Biochemistry 1992, 31:1621-1630.
9. Horlick RA, George HJ, Cooke GM, Tritch RJ, Newton RC, Dwivedi A, Lischwe M, Salemme FR, Weber PC, Horuk R: Permutins of interleukin 1 beta-a simplified approach for the construction of permuted proteins having new termini. Protein Eng 1992, 5:427-431.
10. Zhange T, Bertelsen E, Benvegnu D, Alber T: Circular permutation of T4 lysozyme. Biochemistry 1993, 32:12311-12318.
11. Ay J, Hahn M, Decanniere K, Piotukh K, Borriss R, Heinemann U: Crystal structures and properties of de novo circularly permuted 1,3-1,4-beta-glucanases. Proteins 1998, 30:155-167.
12. Puri RK, Hoon DS, Leland P, Snoy P, Rand RW, Pastan I, Kreitman RJ: Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated pseudomonas exotoxin for therapy of malignant astrocytoma. Cancer Res 1996, 56:5631-5637.
13. Vinais ML, Corbier C, Mulliert G, Branlant C, Branlant G: Circular permutation within the coenzyme binding domain of the tetrameric glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus. Protein Sci 1995, 4:994-1000.
14. Uversky VN, Kutyshenko VP, Protasova N, Rogov VV, Vassilenko KS, Gudkov AT: Circularly permuted dihydrofolate reductase possesses all the properties of the molten globule state, but can resume functional activity by interaction with its ligands. Protein Sci 1996, 5:1844-1851.
15. Viguera AR, Serrano L: Loop length, intramolecular diffusion and protein folding. Nat Struct Biol 1997, 4:939-946.
16. Martinez JC, Viguera AR, Berisio R, Wilmanns M, Mateo PL, Filimonov VV, Serrano L: Thermodynamic analysis of β-spectrin SH3 and two of its circular permutants: Discerning the reasons for rapid folding in proteins. Biochemistry 1999, 38:549-559. A detailed thermodynamic analysis of circular permutants of an SH3 domain.
17. Otzen DE, Fersht AR: Folding of a circularly permuted chymotrypsin inhibitor 2: Retention of the folding nucleus. Biochemistry 1998, 37:8139-8146. A completely circular variant, a circular permutant and the wild-type protein were shown to fold by the same pathway and to have closely similar transition states.
18. Wieligmann K, Norledge B, Jaenicke R, Mayr E-M: Eye lens β2-crystallin: Circular permutation does not influence the oligomeric state but enhances the conformational stability. J Mol Biol 1998, 280:721-729.
19. Hennecke J, Glockshuber R: Conversion of a catalytic into a structural disulfide bond by circular permutation. Biochemistry 1998, 37:17590-17597.
20. Chu V, Freitag S, Le Trong I, Stenkamp RE, Stayton PS: Thermodynamic and structural consequences of flexible loop deletion by circular permutation of the streptavidin-biotin system. Protein Sci 1998, 7:848-859.
21. Iwakura M, Nakamura T: Effects of the length of a glycine linker connecting the N-and C-termini of a circularly permuted dihydrofolate reductase. Protein Eng 1998, 8:707-713.
22. Feng Y, Minnerly JC, Zurfluh LL, Joy WD, Hood WF, Abegg AL, Grabbe ES, Shieh J-J, Thurman TL, McKearn JP, McWherter CA: Circular permutation of granulocyte colony-stimulating factor. Biochemistry 1999, 38:4553-4563. See annotation to [23••].
23. McWherter CA, Feng Y, ZurfLuh L, Klein BK, Baganoff MP, Polazzi JO, Hood WF, Paik K, Abegg AL, Grabbe ES et al.: Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin. Biochemistry 1999, 38:4564-4571. This paper (together with [22••]) describes circular permutants of GCSF, a protein that is currently administered to patients undergoing chemotherapy. Several are successful and, when fused to IL-3, create hybrid molecules with an expanded range of biological activities.
24. MacBeath G, Kast P, Hilvert D: Redesigning enzyme topology by directed evolution. Science 1998, 279:1958-1961. An illustration of the power of genetic selection. Enzyme topology was successfully redesigned by identifying the 1 in 2000 loop sequences that could function as desired.